Trial Search

Current Search Criteria:

Intervention: Gel Vehicle
Found 384 matching trials

Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris

PHASE4

The purpose of the study is to compare the efficacy of three maintenance re...

Status

Completed

Location

KGL, Inc

Start Date

2002-03

Trial ID

NCT00145106

Treatments Being Tested

Tazarotene 0.1% gel + placebo capsule, Oral minocycline (100 mg capsule) + vehicle gel, Tazarotene 0.1% gel + oral minocycline (100 mg capsule)

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

PHASE2

The purpose of this study is to determine whether a glaucoma therapy is saf...

Status

Completed

Location

United States Investigative Sites in Texas and Other States

Start Date

2005-11

Trial ID

NCT00287521

Treatments Being Tested

AL-37807 Ophthalmic Suspension, 1.0%Latanoprost, 0.005% (Xalatan)AL-37807 VehicleTimolol Maleate Ophthalmic Gel Forming Solution, 0.5%

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

PHASE2

The goal of this clinical trial is to learn about HT-001 Topical Gel for tr...

Status

Recruiting

Location

UCI Health - CIACC

Start Date

2023-07-19

Trial ID

NCT05639933

Treatments Being Tested

HT-001 2% Topical GelHT-001 1% Topical GelHT-001 0.5% Topical GelHT-001 Placebo

Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

PHASE1

Patients in the severe stages of Chronic limb-threatening ischemia (CLTI) a...

Status

Completed

Location

Fundación Oftalmológica de Santander (FOSCAL)

Start Date

2019-01-01

Trial ID

NCT05631444

Treatments Being Tested

Cell-based therapy

An Open Label, Single Treatment, Single Arm, Multiple Dose Phase-2 Study to Evaluate the Pharmacokinetics, Safety, and Clinical Performance of EscharEx (EX-03) in Participants With Venous Leg Ulcers

PHASE2

This is a pharmacokinetics (PK) study - the main objective of this study is...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-08

Trial ID

NCT07692178

Treatments Being Tested

EX-03

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

PHASE1

A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Stu...

Status

Completed

Location

KGL, Inc

Start Date

2012-11

Trial ID

NCT01755247

Treatments Being Tested

Topical Gel Vehicle8% NVN1000 Topical Gel8% NVN1000 Topical Gel and moisturizer

Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts

PHASE3

A clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% form...

Status

Completed

Location

Leon Medical Research

Start Date

2018-04-20

Trial ID

NCT03532776

Treatments Being Tested

Podofilox Gel 0.5%Condylox Topical Gel 0.5%Placebo Gel

Diabetic Neuropathy Topical Treatment

PHASE3

Comparative study of efficacy and safety of ketamine, clonidine, mixture of...

Status

Unknown

Location

Santa Casa de São Paulo

Start Date

2008-04

Trial ID

NCT00661063

Treatments Being Tested

ketaminevehicle gelketamine + clonidineclonidine gel 1%

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

PHASE1

This was a single-center, evaluator-blinded, randomized, placebo (vehicle) ...

Status

Completed

Location

Multiple Locations

Start Date

2008-11-21

Trial ID

NCT01915758

Treatments Being Tested

clindamycin1%/tretinoin 0.025% gelvehicle gel

A Study to Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants

PHASE1

The purpose of this study is to evaluate skin irritation and photo irritati...

Status

Completed

Location

Multiple Locations

Start Date

2011-08

Trial ID

NCT01494714

Treatments Being Tested

JNJ 10229570-AAA 1.2% creamJNJ 10229570-AAA 2.4% creamJNJ 10229570-AAA 3.6% creamColor-matched vehicle in a cream formulation containing 0 mg of JNJ 10229570-AAAPetroleum jelly
PreviousNext